DIKUL - logo
E-resources
Full text
Peer reviewed Open access
  • Viewing RCC with a DNA Meth...
    Zhou, Mi; Kim, William Y

    Clinical cancer research, 04/2023, Volume: 29, Issue: 7
    Journal Article

    Clear-cell renal cell carcinoma tumors with an enhancer demethylator phenotype (TED) harbor a worse prognosis and derive less clinical benefit from immunotherapy. The TED phenotype may help predict immunotherapy resistance. See related article by Lu et al., p. 1279.